LIVZON PHARMA Publishes 8 Sep 2026 Circular and First EGM Notice; Highlights Shift to E-Communication

Bulletin Express
09/08

On 8 September 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released two key corporate documents on both its corporate website (www.livzon.com.cn) and Hong Kong Stock Exchange’s HKEXnews platform:

• Circular dated 8 September 2026 • Notice and Proxy Form for the 2026 First Extraordinary General Meeting (EGM)

The company emphasizes digital access, recommending shareholders consult the online versions to expedite information flow and reduce printing costs. Shareholders who previously elected to receive hard copies will find the printed package enclosed with the notification.

Action options for registered shareholders: 1. Continue with electronic delivery—ensure a valid email address is on file to receive future publication alerts and actionable communications. 2. Switch to printed copies—complete and return the enclosed request form to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid label or email 1513-ecom@vistra.com. Printed materials will be provided free of charge.

Deadlines and contacts: • The current instruction on preferred communication format remains valid until 31 December 2026 unless revised by written notice. • Shareholder enquiries can be directed to Tricor’s hotline at +852 2980 1333 (09:00–18:00, Monday–Friday, excluding public holidays).

The notification underscores shareholders’ responsibility to maintain an active email address; absent a functional address, the company will default to mailing physical notices until digital details are updated.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10